Successful Management of Ibrutinib-Induced Thrombocytopenia in a Patient with Chronic Lymphocytic Leukemia: No Interruption, Only Reduction

Successful Management of Ibrutinib-Induced Thrombocytopenia in a Patient with Chronic Lymphocytic Leukemia: No Interruption, Only Reduction [Turk J Hematol]

Turk J Hematol. 2024; 41(1): 55-56 | DOI: 10.4274/tjh.galenos.2023.2023.0426

Successful Management of Ibrutinib-Induced Thrombocytopenia in a Patient with Chronic Lymphocytic Leukemia: No Interruption, Only Reduction

Simge Erdem, Meliha Nal�ac�
�stanbul University, �stanbul Faculty of Medicine, Department of Internal Medicine, Division of Hematology, �stanbul, T�rkiye

Keywords: B-cell neoplasms, Chronic lymphocytic leukemia, Ibrutinib, Megakaryocytes, Thrombocytopenia

Kronik Lenfositik L�semili Bir Hastada �brutinibe Ba�l� Trombositopeninin Ba�ar�l� Y�netimi: �lac� Kesme, Doz Azalt

Simge Erdem, Meliha Nal�ac�
�stanbul University, �stanbul Faculty of Medicine, Department of Internal Medicine, Division of Hematology, �stanbul, T�rkiye

Anahtar Kelimeler: B-h�creli neoplaziler, Kronik lenfositik l�semi, �brutinib, Megakaryositler, Trombositopeni

Simge Erdem, Meliha Nal�ac�. Successful Management of Ibrutinib-Induced Thrombocytopenia in a Patient with Chronic Lymphocytic Leukemia: No Interruption, Only Reduction. Turk J Hematol. 2024; 41(1): 55-56

Corresponding Author: Simge Erdem, T�rkiye

TOOLS

Full Text PDF

Download citation

RIS

EndNote

BibTex

Medlars

Procite

Reference Manager

Share with email

Send email to author

Similar articles

PubMed

Google Scholar

In authors and institutes

In titles and abstracts

In keywords

In all


	E-ISSN: 1308-5263
Archive Most Accessed Articles Most Cited Articles Aims and Scope Instructions For Authors Editorial Board Advisory Board Manuscript Submission Why to Submit Search Contact